BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12509841)

  • 21. The Lambert-Eaton myasthenic syndrome.
    Sanders DB
    Adv Neurol; 2002; 88():189-201. PubMed ID: 11908225
    [No Abstract]   [Full Text] [Related]  

  • 22. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL; Voltz R; Kuempfel T
    Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
    Blandino JK; Kim YI
    Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitory action of Lambert-Eaton syndrome IgG on calcium currents in a thyroid C-cell line.
    Kim YI; Blandino JK; O'Shaughnessy TJ
    Ann N Y Acad Sci; 1993 Jun; 681():398-401. PubMed ID: 8395154
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of autoantibodies in Lambert-Eaton myasthenic syndrome.
    Lang B; Waterman S; Pinto A; Jones D; Moss F; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Motomura M; Moll JW; Vincent A; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():596-605. PubMed ID: 9668304
    [No Abstract]   [Full Text] [Related]  

  • 26. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.
    Newsom-Davis J; Leys K; Vincent A; Ferguson I; Modi G; Mills K
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):452-3. PubMed ID: 1650816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal staining patterns in sera from patients with Lambert-Eaton myasthenic syndrome.
    Polizzi A; Lang B; Amyes E; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 1998 May; 841():684-6. PubMed ID: 9668314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lambert-Eaton myasthenic syndrome].
    Takamori M
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1903-11. PubMed ID: 9788200
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome.
    Sher E; Comola M; Nemni R; Canal N; Clementi F
    Lancet; 1990 Feb; 335(8686):413. PubMed ID: 1968140
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-paraneoplastic voltage-gated calcium channels antibody-mediated cerebellar ataxia responsive to IVIG treatment.
    Rigamonti A; Lauria G; Stanzani L; Mantero V; Andreetta F; Salmaggi A
    J Neurol Sci; 2014 Jan; 336(1-2):169-70. PubMed ID: 24215945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX1 autoantibodies: tumor markers in LEMS patients?
    Lang B; Evoli A
    Neurology; 2008 Mar; 70(12):906-7. PubMed ID: 18347313
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lambert-Eaton myasthenic syndrome(LEMS)].
    Inuzuka T
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):377-9. PubMed ID: 11031974
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lambert-Eaton myasthenic syndrome].
    Fukunaga H
    Ryoikibetsu Shokogun Shirizu; 2001; (36):354-8. PubMed ID: 11596409
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.
    Engel AG
    Ann N Y Acad Sci; 1991; 635():246-58. PubMed ID: 1660237
    [No Abstract]   [Full Text] [Related]  

  • 36. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy.
    Takamori M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1347-51. PubMed ID: 15336982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
    Pinto A; Moss F; Lang B; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():687-90. PubMed ID: 9668315
    [No Abstract]   [Full Text] [Related]  

  • 38. Lambert-Eaton myasthenic syndrome following H1N1-influenza vaccination: a case report.
    Ansakorpi H; Rusanen H; Rytky S; Färkkilä M
    Acta Neurol Scand; 2012 Nov; 126(5):e25-8. PubMed ID: 22571392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lambert-Eaton syndrome].
    Osterhage J; Jost WH; Schimrigk K
    Med Klin (Munich); 1996 Aug; 91(8):526-30. PubMed ID: 8965753
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
    Sher E; Carbone E; Clementi F
    Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.